Portuguese Centre for Fertility Preservation Centro de Preservação da Fertilidade The Portuguese Centre for Fertility Preservation (in the Reproductive Department of the Coimbra Hospital and University Centre) is the only public centre of the country and it was created in 2010 to fulfill the reproductive…
Rede Brasileira de Oncofertilidade – reBOC The Brazilian Oncofertility Consortium® (BOC) was officially created in 2013. Known nationally in Brazil as Rede Brasileira de Oncofertilidade – reBOC, the network whose director is Dr. Jhenifer Rodrigues, PhD, gathers professional members together to share experiences, materials, research…
In 2012 Main Line Fertility Center joined the Oncofertility Consortium at Northwestern University and launched an official Fertility Preservation Program. This program was created to educate recently diagnosed cancer patients about their options and to increase access to fertility preservation procedures during the small window of opportunity…
Testicular tissue cryopreservation is an option for prepubertal patients who are not producing sperm and therefore are unable to preserve a semen sample. It is important to emphasize that the methods described here are experimental, and that only a limited number of patients have cryopreserved…
Pediatric and Adolescent Committee (PAC) – formally known as the Pediatric Initiative Network (PIN) is one of the scientific committees of the Oncofertility Consortium (OFC). It’s an international group of providers dedicated to preserving and protecting the fertility of children and adolescents at risk for…
Application of an alginate 3-D culture system to the maturation of primate follicles in vitro and delivery of pro-angiogenic agents to autotransplanted ovarian tissue
Bridging the gap between oncology and reproductive medicine and help patients navigate the available fertility preservation options and provide individual solutions based on factors such as age, partnership status, time constraints prior to cancer treatment, planned treatment regimen and overall medical condition
The application of biomaterials and tissue engineering to reproductive biology provides an enabling technology that is central to the Oncofertility Consortium
Evaluating the economic factors, decision-making rules, and risk-benefit analyses of accessing fertility conserving options when the outcomes are not known
Assessing how adult women diagnosed with cancer and their doctors discuss issues regarding fertility and make treatment choices, and how fertility impacts women’s lives after cancer
Advancement of training opportunities for the interdisciplinary, globally prepared oncofertility scholar, including site-specific exchange of investigators
Facilitation of communication and data sharing governance to remove barriers to progress and provide a framework for operations, goverance and support of interdisciplinary Oncofertility Consortium members
Investigation of novel and cutting-edge technologies, tools, and training activities for assessing fertility status and the sequelae of adverse fertility outcomes in pediatric cancer patients
Clarifying the mechanism of oocyte death and identifying molecular targets for treatment that can protect the ovary from damage caused by cancer therapies
Site: Northwestern University Principal Investigator: Teresa K. Woodruff, PhD Rationale The overarching purpose of the Oncofertility Consortium is to address the fertility threat posed by today’s highly effective cancer treatments in young men, women, and children and to serve as an authoritative voice for research,…
